• This event has passed.

A CPhA Virtual Town Hall

April 23 @ 6:00 pm - 6:45 pm

Membership in CPhA is required to take part in the Virtual Town Hall

 

As pharmacy professionals, you remain on the front lines of care. As your association, we are ensuring that the needs of the profession and your health are respected by all government agencies. With the influx of information published on a moment-by-moment basis, the California Pharmacists Association invites you to a brief, thirty-minute Virtual Town Hall to understand the current state of affairs for pharmacy professionals and COVID-19.

In addition to hearing the latest news, the Virtual Town Hall is an opportunity for you, our valued member, to tell us what you need. We count on the input from our members to move our profession forward and provide valuable feedback about how we can work with government agencies and stakeholders to meet your needs.

Questions? Please contact Sheila Johnston, Vice-President, Member Development & Communications at sjohnston@cpha.com.


Continuing Education: COVID-19 Testing – What is an Emergency Use Authorization?

Description

Due to the urgent nature of the public health crisis caused by Coronavirus Disease-19 (COVID-19), the FDA has enacted its emergency use authorization (EUA) authority to facilitate availability of in vitro diagnostic products for COVID-19. Pharmacists play an important role in responding to COVID-19 and increasing access to urgently needed testing. Recently, the U.S. Department of Health & Human Services authorized pharmacists to order and administer tests for COVID-19. As pharmacists navigate COVID-19, it is important to understand the FDA regulatory process to be able to identify legible, reliable, and non-fraudulent products.

Learning Objectives

At the completion of this activity, participants will be able to:

  • Describe the regulatory process for FDA-approved home and lab tests
  • Explain the FDA’s emergency use authorization (EUA) as it pertains to COVID-19 in vitro diagnostic products
  • Discuss the FDA’s policy for diagnostic tests for COVID-19
  • Identify non-fraudulent COVID-19 in vitro diagnostic products authorized or cleared to develop and distribute without an EUA

Speakers

  • Susan Bain, DRSc, Assistant Professor of Regulatory and Quality Sciences, University of Southern California School of Pharmacy

Registration Fees

Fee 
CPhA Member   $0
Non-Member   N/A

 

Register Now

 

Continuing Pharmacy Education (CPE) Information

The California Pharmacists Association (#0113) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Upon completing an evaluation form, participants will be awarded 0.5 hours (0.05 CEUs) of Continuing Pharmacy Education Credit. A statement of credit will not be issued. Participants may log onto the CPE monitor website using their individual log in to download their statement of credit. Please allow 4 weeks for processing of CPE credits to the CPE monitor. UAN: 0113-0000-20-101-L04-P; 0113-0000-20-101-L04-T; 0113-0000-20-101-H04-P; 0113-0000-20-101-H04-T

Activity Type:  Knowledge-based
Target Audience:  Pharmacists and Technicians in all practice settings
Release Date: 4/14/2020
Expiration Date: 4/14/2023

Details

Date:
April 23
Time:
6:00 pm - 6:45 pm

Venue

Online Webinar
United States